Showing results (301-310 of 330) with videos related to
Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III StudyLin Shen, Ken Kato, Sung-Bae Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A Shah, Kei Muro, et al.European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancerManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.Frontiers in Oncology|April 7, 2023
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trialSusanne Wiegand, Gunnar Wichmann, Jeannette Vogt, et al.Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.BMC Cancer|March 18, 2014
Imagine a world without cancerBjörn L D M Brücher, Gary Lyman, Richard van Hillegersberg, et al.Journal of Cancer Research and Clinical Oncology|October 14, 2022
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemicVolker Arndt, Daniela Doege, Stefan Fröhling, et al.European Journal of Cancer (Oxford, England : 1990)|June 3, 2016
Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancerManfred P Lutz, John R Zalcberg, Rob Glynne-Jones, et al.The New England Journal of Medicine|January 22, 2025
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal CancerJens Hoeppner, Thomas Brunner, Claudia Schmoor, et al.European Journal of Cancer (Oxford, England : 1990)|February 12, 2025
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapyNicolas Cabrit, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.Pageof 33